Difference between revisions of "DZI20-210-Case-18"

From MGH Learn Pathology
(Automatic edit to upgrade to new templates)
(Updating subject, access, and performer)
Line 12: Line 12:
 
IHC: Atypical cells positive for CD3, CD7, CD30, and CD56 with expression of cytotoxic granules (TIA-1, granzyme B) and negative for CD4, CD5, CD8, Bf1 (TCR alpha/beta) and TCR gamma. TCR gamma gene rearragement.
 
IHC: Atypical cells positive for CD3, CD7, CD30, and CD56 with expression of cytotoxic granules (TIA-1, granzyme B) and negative for CD4, CD5, CD8, Bf1 (TCR alpha/beta) and TCR gamma. TCR gamma gene rearragement.
 
|reasonCode=NA
 
|reasonCode=NA
|subject=public
+
|subject=MGH
|performer=Vn048
+
|performer=VN048
 
|authoredOn=October 21, 2020 03:11:14 PM
 
|authoredOn=October 21, 2020 03:11:14 PM
 
|requester=Vn048
 
|requester=Vn048
 
|sequence=18
 
|sequence=18
 +
|access=public
 
}}
 
}}
 
{{Media
 
{{Media

Revision as of 15:17, June 21, 2022

DZI20-210-Case-18
NA
SKIN, LEFT CHEST, SKIN PUNCH BIOPSY, GAMMA DELTA T CELL LYMPHOM. IHC: Atypical cells positive for CD3, CD7, CD30, and CD56 with expression of cytotoxic granules (TIA-1, granzyme B) and negative for CD4, CD5, CD8, Bf1 (TCR alpha/beta) and TCR gamma. TCR gamma gene rearragement.
December 31, 1969 7:00:00 PM